1. MicroRNA expression profiling in patients with hepatocellular carcinoma of familial aggregation and hepatitis B virus infection
   Er-Lei Zhang et al, 2017, Oncology Letters CrossRef
2. YAP transcriptionally regulates ErbB2 to promote liver cell proliferation
   Evan Y. Wang et al, 2018, Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms CrossRef
3. Leveraging metformin to combat hepatocellular carcinoma: its therapeutic promise against hepatitis viral infections
   Ali Shojaeian et al, 2024, Journal of Cancer Metastasis and Treatment CrossRef
4. Hepatocellular carcinoma: molecular mechanism, targeted therapy, and biomarkers
   Yu Wang et al, 2023, Cancer and Metastasis Reviews CrossRef
5. Hepatitis B virus X protein enhances the development of liver fibrosis and the expression of genes associated with epithelial-mesenchymal transitions and tumor progenitor cells
   James Ahodantin et al, 2020, Carcinogenesis CrossRef
6. Identification of a Yorkie homolog from Litopenaeus vannamei as a negative regulator in anti-WSSV immune response
   Jie Ren et al, 2022, Fish & Shellfish Immunology CrossRef
7. Progress in research on association between cell signal transduction pathways and hepatocellular carcinoma
   Chun Chen et al, 2019, World Chinese Journal of Digestology CrossRef
8. Influenza A virus NS1 protein hijacks YAP/TAZ to suppress TLR3-mediated innate immune response
   Qiong Zhang et al, 2022, PLOS Pathogens CrossRef
9. Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells
   Yanrong Zhou et al, 2023, International Journal of Molecular Sciences CrossRef
10. Advances in prognostic and therapeutic targets for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: The hippo signaling pathway
    Geofrey Mahiki Mranda et al, 2022, Frontiers in Oncology CrossRef
11. Oncolytic Newcastle disease virus induced degradation of YAP through E3 ubiquitin ligase PRKN to exacerbate ferroptosis in tumor cells
    Yifan Sun et al, 2024, Journal of Virology CrossRef
12. A System Based-Approach to Examine Host Response during Infection with Influenza A Virus Subtype H7N9 in Human and Avian Cells
    Biruhalem Taye et al, 2020, Cells CrossRef
13. Molecular pathways in viral hepatitis-associated liver carcinogenesis: An update
    Gulsum Ozlem Elpek, 2021, World Journal of Clinical Cases CrossRef
14. Atorvastatin favorably modulates a clinical hepatocellular carcinoma risk gene signature
    Myung‐Ho Kim et al, 2022, Hepatology Communications CrossRef
15. White Spot Syndrome Virus (WSSV) Inhibits Hippo Signaling and Activates Yki To Promote Its Infection in Penaeus vannamei
    Linwei Yang et al, 2023, Microbiology Spectrum CrossRef
16. A derivant of ginsenoside CK and its inhibitory effect on hepatocellular carcinoma
    Jingjing Zhang et al, 2022, Life Sciences CrossRef
17. The Hippo Pathway and Viral Infections
    Zhilong Wang et al, 2020, Frontiers in Microbiology CrossRef
18. Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer
    Giulia Schiavoni et al, 2024, Journal of Translational Medicine CrossRef